Infographic: Yidu Tech's H1 FY2026 Results Show Significant Profitability Surge

On November 27, Yidu Tech (2158.HK), a leading Chinese AI healthcare company, released its interim results announcement for fiscal year 2026 and held an earnings press conference. During the reporting period, the company maintained healthy business growth, with total revenue increasing by 8.7% year-on-year to RMB 358 million. Notably, the company achieved significant improvements in profitability quality and operational efficiency: adjusted EBITDA from existing operations doubled compared to the same period last year, reaching approximately RMB 54 million, while its financial statements approached break-even, achieving this milestone one year ahead of management’s previous expectations.

Strong business growth momentum was evident, with new orders in core segments also showing significant increases. Specifically, new orders for the Big Data Platform and Solutions segment rose by 19.7% year-on-year, while those for the Life Sciences Solutions segment surged by 61.1% year-on-year.

Management stated at the meeting: “Currently, the company’s large language model (LLM) technology has entered a new phase characterized by ‘diversified applications and large-scale implementation.’ This assessment is based on implementations across three dimensions: First, deep integration in top-tier hospitals, where the company’s AI middle platform has been deployed in more than 30 Grade A tertiary hospitals, with the Doctor Copilot achieving high-frequency usage of nearly 1,000 calls per day in individual hospitals; second, precise empowerment of key specialties, with a significant improvement in the accuracy of the TNM staging assessment agent; and third, intelligent integration of expertise from leading specialists, as the company leverages doctors’ ‘digital avatars’ to extend experts’ clinical experience to serve patients more broadly.”